Page last updated: 2024-11-03

prazosin and Hyperlipidemias

prazosin has been researched along with Hyperlipidemias in 12 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Hyperlipidemias: Conditions with excess LIPIDS in the blood.

Research Excerpts

ExcerptRelevanceReference
" This result was not significant but suggested a favorable effect of terazosin on diminishing the risk of coronary heart disease."9.09[Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy]. ( Kageyama, S; Tamaki, M; Ueda, T, 1999)
"The paper deals with the study into the benefits of prazosin and trasicor used in arterial hypertension."9.06[Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor]. ( Damiĭonaĭtene, RA; Kuchinskene, ZZ; Rugenius, IuIu; Steponenene, RV; Vidugiris, AI, 1990)
" This result was not significant but suggested a favorable effect of terazosin on diminishing the risk of coronary heart disease."5.09[Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy]. ( Kageyama, S; Tamaki, M; Ueda, T, 1999)
"The paper deals with the study into the benefits of prazosin and trasicor used in arterial hypertension."5.06[Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor]. ( Damiĭonaĭtene, RA; Kuchinskene, ZZ; Rugenius, IuIu; Steponenene, RV; Vidugiris, AI, 1990)
" In this article, doxazosin is reviewed for its efficacy in the treatment of severe essential hypertension and specific complications or conditions of mild or moderate essential hypertension, namely, left ventricular hypertrophy, hyperlipidemia, noninsulin-dependent diabetes mellitus, renal insufficiency, pheochromocytoma, chronic obstructive pulmonary disease, peripheral vascular disease, and smoking."4.78Efficacy of doxazosin in specific hypertensive patient groups. ( Taylor, SH, 1991)
" Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia."3.75Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009)
"Prazosin (Minipress) monotherapy was given to 152 patients with essential hypertension for one year in a multi-center study involving 13 hospitals and university clinics."3.68[The anti-lipidemic effect of Minipress]. ( Dudás, M; Farsang, C; Földes, I; Iványi, J; Pados, G, 1990)
" No unknown adverse reactions were observed in either groups, and the drugs were shown to be highly safe."2.70[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy]. ( Fujioka, T; Goto, Y; Isurugi, K; Katoh, T; Numasato, S; Obara, W; Omori, S; Suzuki, Y, 2001)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's6 (50.00)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, KP1
Lin, HL1
Hsieh, SL1
Kwan, AL1
Chen, IJ1
Wu, BN1
Yokoyama, M1
Akita, H1
Mizutani, T1
Fukuzaki, H1
Watanabe, Y1
Mitchell, G1
Wiss, G1
Learner, J1
Korkigian, A1
Sheu, JR1
Peng, IH1
Lee, YM1
Yen, MH1
Tamaki, M1
Ueda, T1
Kageyama, S1
Suzuki, Y1
Katoh, T1
Isurugi, K1
Obara, W1
Omori, S1
Goto, Y1
Fujioka, T1
Numasato, S1
Kowala, MC1
Nunnari, JJ1
Durham, SK1
Nicolosi, RJ1
Taylor, SH1
Rugenius, IuIu1
Damiĭonaĭtene, RA1
Kuchinskene, ZZ1
Vidugiris, AI1
Steponenene, RV1
Pados, G1
Iványi, J1
Földes, I1
Dudás, M1
Farsang, C1
Nafstad, I1
Tollersrud, S1
Eriksen, K1
Helgeland, A1
Solberg, LA1
Bredesen, J1
Dale, O1
Metelitsa, VI1
Oganov, RG1

Reviews

1 review available for prazosin and Hyperlipidemias

ArticleYear
Efficacy of doxazosin in specific hypertensive patient groups.
    American heart journal, 1991, Volume: 121, Issue:1 Pt 2

    Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Cardiomegaly; Diabetes Mellitus, Type 2; Doxazosin

1991

Trials

3 trials available for prazosin and Hyperlipidemias

ArticleYear
[Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:12

    Topics: Aged; Coronary Disease; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Prazosin; Prostatic Hype

1999
[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy].
    Hinyokika kiyo. Acta urologica Japonica, 2001, Volume: 47, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prazos

2001
[Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor].
    Kardiologiia, 1990, Volume: 30, Issue:7

    Topics: Adult; Antihypertensive Agents; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents;

1990

Other Studies

8 other studies available for prazosin and Hyperlipidemias

ArticleYear
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:4

    Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut

2009
Hyperreactivity of coronary arterial smooth muscles in response to ergonovine from rabbits with hereditary hyperlipidemia.
    Circulation research, 1983, Volume: 53, Issue:1

    Topics: Animals; Aorta, Thoracic; Carotid Arteries; Cholesterol; Coronary Vessels; Cyproheptadine; Ergonovin

1983
Effects of antihypertensives on blood lipids.
    Postgraduate medicine, 1982, Volume: 72, Issue:4

    Topics: Humans; Hyperlipidemias; Male; Prazosin; Quinazolines

1982
Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressur

1996
Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters.
    Atherosclerosis, 1991, Volume: 91, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Cholestero

1991
[The anti-lipidemic effect of Minipress].
    Orvosi hetilap, 1990, May-27, Volume: 131, Issue:21

    Topics: Coronary Disease; Drug Evaluation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Hypo

1990
The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet.
    General pharmacology, 1988, Volume: 19, Issue:5

    Topics: Animals; Arteriosclerosis; Atenolol; Body Weight; Cholesterol, Dietary; Diet; Female; gamma-Glutamyl

1988
System approach to testing hypotensive drugs for prevention of arterial hypertension.
    Cor et vasa, 1987, Volume: 29, Issue:5

    Topics: Clinical Trials as Topic; Humans; Hydralazine; Hyperlipidemias; Hypertension; Prazosin; Propranolol

1987